Skip to main content
SpringerLink
Log in

Pelargonium sidoides-Extrakt (EPs® 7630): Zulassung bestätigt Wirksamkeit und Verträglichkeit

Pelargonium sidoides-extract (EPs® 7630): registration confirms efficacy and safety

  • Themenschwerpunkt
  • Published:
Wiener Medizinische Wochenschrift Aims and scope Submit manuscript

Summary

For centuries the roots of Pelargonium sidoides DC have been used in South African ethno-medicine for the treatment of respiratory diseases. In Germany, a medicinal product containing a special extract of this substance is among the group of self-medication products most widely bought at chemist's shops. In December 2005, the Federal Institute for Drugs and Medical Devices (BfArM, Bonn) approved a new license for its use as a drug. The following review focuses on the current pharmacological, toxicological and clinical data covering the efficacy and innocuousness of this drug when administered for the treatment of acute bronchitis.

Zusammenfassung

Wurzelstücke aus Pelargonium sidoides DC werden in der südafrikanischen Ethnomedizin seit Jahrhunderten zur Behandlung von Atemwegserkrankungen angewendet. Ein Fertigarzneimittel mit einem speziellen Extrakt aus dieser Droge zählt gegenwärtig in Deutschland zu den Selbstmedikationspräparaten, die in der Apotheke am häufigsten abgegeben werden. Das Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM, Bonn) hat dem Präparat im Dezember 2005 eine Neuzulassung als Arzneimittel erteilt. Die nachfolgende Übersicht fokussiert sich auf die aktuellen pharmakologischen, toxikologischen und klinischen Daten zur Wirksamkeit und Unbedenklichkeit im neu zugelassenen Anwendungsgebiet akute Bronchitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Literatur

  • Lis-Balchin M (2002) Geranium and Pelargonium. Taylor & Francis, London

    Google Scholar 

  • Kolodziej H (2002) Pelargonium reniforme and Pelargonium sidoides: their botany, chemistry and medicinal use. In: Lis-Balchin M (ed.) Geranium and Pelargonium. Taylor & Francis, London, 262–290

    Google Scholar 

  • Conrad A, Schulz V (2007) Umckaloabo® bei akuter Bronchitis. Dtsch Apoth Ztg 147: 75–79

    Google Scholar 

  • Kayser O, Kolodziej H, Gutman M (1995) Arzneilich verwendete Pelargonien aus Südafrika. Dtsch Apoth Ztg 135: 853–864

    Google Scholar 

  • Kolodziej H, Kayser O (1998) Pelargonium sidoides DC – Neueste Erkenntnisse zum Verständnis des Phytotherapeuticums Umckaloabo. Z Phytother 19: 141–151

    Google Scholar 

  • Kolodziej H (2007) Fascinating metabolic pools of Pelargonium sidoides and Pelargonium reniforme, traditional and phytomedicinal sorces of the herbal medicine Umckaloabo®. Phytomedicine 14(Suppl VI): 9–17

    Article  PubMed  CAS  Google Scholar 

  • Kolodziej H, Schulz V (2003) Umckaloabo. Deutsche Apotheker Zeitung 143: 1303–1312

    Google Scholar 

  • Kolodziej H, Kayser O, Radtke OA, Kiderlen AF, Koch E (2003) Pharmacological profile of extracts of Pelargonium sidoides and their constituents. Phytomedicine 10 Suppl IV: 18–24

    Article  PubMed  CAS  Google Scholar 

  • Kayser O, Kolodziej H, Kiderlen AF (2001) Immunomodulatory Principles of Pelargonium sidoides. Phytother Res 15: 122–126

    Article  PubMed  CAS  Google Scholar 

  • Kolodziej H, Burmeister A, Trun W, Radtke OA, Kiderlen AF, Ito H, Hatano T, Yoshida T, Foo LY (2005) Tannins and related compounds induce nitric oxide synthase and cytokines gene expression in Leishmania major-infected macrophage-like RAW 264.7 cells. Bioorg Med Chem 13: 6470–6476

    Article  PubMed  CAS  Google Scholar 

  • Trun W, Kiderlen AF, Kolodziej H (2006) Nitric oxide synthase and cytokines gene expression analyses in Leishmania-infected RAW 264.7 cells treated with an extract of Pelargonium sidoides (EPs® 7630). Phytomedicine 13: 570–575

    Article  PubMed  CAS  Google Scholar 

  • Conrad A, Hansmann C, Engels I, Daschner FD, Frank U (2007a) Extract of Pelargonium sidoides (EPs® 7630) improves phagocytosis, oxidative burst, and intracellular killing of human peripheral blood phagocytes in-vitro. Phytomedicine 14(Suppl VI): 46–51

    Article  Google Scholar 

  • Conrad A, Jung I, Tioua D, Lallemand C, Carrapatoso F, Engels I, Daschner FD, Frank U (2007b) Extract of Pelargonium sidoides (EPs® 7630) inhibits the interactions of group A streptococci and host epithelia in-vitro. Phytomedicine 14(Suppl VI): 52–59

    Article  Google Scholar 

  • Kolodziej H, Kiderlen AF (2007) In vitro Evaluation of Antibacterial and Immunomodulatory Activities of Pelargonium reniforme, Pelargonium sidoides and the related herbal drug preparation EPs® 7630. Phytomedicine 14(Suppl VI): 18–26

    Article  PubMed  CAS  Google Scholar 

  • Nöldner M, Schötz K (2007) Inhibition of Lipopolysaccharid-Induced Sickness Behavior by a Dry Extract from the Roots of Pelargonium sidoides (EPs® 7630) in Mice. Phytomedicine 14(Suppl VI): 27–31

    Article  PubMed  Google Scholar 

  • Schötz K, Nöldner M (2007) Mass spectroscopic characterization of oligomeric proanthocyanidins derived from an extract of Pelargonium sidoides roots (EPs® 7630) and pharmacological screening in CNS models. Phytomedicine 14(Suppl VI): 32–39

    Article  PubMed  CAS  Google Scholar 

  • Neugebauer P, Mickenhagen A, Siefer O, Walger M (2005) A new approach to pharmacological effects on ciliary beat frequency in cell cultures – exemplary measurements under Pelargonium sidoides extract. Phytomedicine 12: 47–52

    Article  Google Scholar 

  • Koch E (2006) Untersuchungen zu möglichen hepatotoxischen Effekten von Umckaloabo®. Z Phytother (Suppl 27): S25

  • Koch K, Biber A (2007) Treatment of rats with the Pelargonium sidoides extract EPs® 7630 has no effect on blood coagulation parameters or on the pharmacokinetics of warfarin. Phytomedicine 14(Suppl VI): 40–45

    Article  PubMed  CAS  Google Scholar 

  • Chuchalin AG, Berman B, Lehmacher W (2005) Treatment of acute bronchitis in adults with a Pelargonium sidoides preparation (EPs® 7630): A randomized, doubleblind, placebo-controlled trial. Explore 1: 437–445

    PubMed  CAS  Google Scholar 

  • Matthys H, Heger M (2007) Treatment of Acute Bronchitis with a Liquid Herbal Drug Preparation from Pelargonium sidoides (EPs® 7630): A Randomised, Double-Blind, Placebo-Controlled, Multi-Centre Study. Curr Med Res Opin 23: 323–331

    Article  PubMed  CAS  Google Scholar 

  • Blochin B, Haidvogl M, Heger M (1999) Umckaloabo im Vergleich zu Acetylcystein bei Kindern mit akuter Bronchitis. Der Kassenarzt 49: 46–49

    Google Scholar 

  • Haidvogl M, Heger M (2007) Treatment Effect and Safety of EPs® 7630 solution in Acute Bronchitis in Childhood – Report of a multicentre observational study. Phytomedicine 14(Suppl VI): 60–64

    Article  PubMed  Google Scholar 

  • Matthys H, Heger M (2007) EPs® 7630 solution – an effective therapeutic option in acute and exacerbating bronchitis. Phytomedicine 14(Suppl VI): 65–68

    Article  PubMed  Google Scholar 

  • Matthys H, Kamin W, Funk P, Heger M (2007) Pelargonium sidoides preparation (EPs® 7630) in the treatment of acute bronchitis in adults and children. Phytomedicine 14(Suppl VI): 69–73

    Article  PubMed  Google Scholar 

  • Roots I, Arold G, Dienel A, Meng G, Wollny A, Bauer S (2004) Placebokontrollierte doppelblinde Interaktionsstudie mit Pelargonium-sidoides-Extrakt und Penicillin V bei gesunden Probanden. Phytopharmaka und Phytotherapie 2004 – Forschung und Praxis, Berlin. Abstract

  • Bent B, Saint S, Vittinghoff E, Grady D (1999) Antibiotics in acute bronchitis: a metaanalysis. Am J Med 107: 62–67

    Article  PubMed  CAS  Google Scholar 

  • Dietl R, Müller J (2002) Anwendungsbeobachtung gemäß § 67.6 AMG mit EPs 7630. Biometrischer Bericht. Dr. Willmar Schwabe Arzneimittel GmbH, Karlsruhe

  • Anonymus (2004) Periodic Safety Update Report on the Tolerability of Pelargonium sidoides Extract EPs 7630. ISO Pharma, Ettlingen

Download references

Author information

Authors and Affiliations

  1. Institut für Umweltmedizin und Krankenhaushygiene, Universitätsklinikum Freiburg, Freiburg, Germany

    Andreas Conrad

  2. Institut für Pharmazie, Pharmazeutische Biologie, Freie Universität Berlin, Berlin, Germany

    Herbert Kolodziej

  3. Berlin, Germany

    Volker Schulz

Authors
  1. Andreas Conrad
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Herbert Kolodziej
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Volker Schulz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Volker Schulz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Conrad, A., Kolodziej, H. & Schulz, V. Pelargonium sidoides-Extrakt (EPs® 7630): Zulassung bestätigt Wirksamkeit und Verträglichkeit. Wien Med Wochenschr 157, 331–336 (2007). https://doi.org/10.1007/s10354-007-0434-6

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10354-007-0434-6

Keywords

Schlüsselwörter

Search

Navigation